Assignee
LEO PHARMA AS
DK·41 granted patents·39 pending applications·162 citations·filing 1993–2025
Top patents by PatentIndex Score
80 records- 0187US11065257B2Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2017·Granted Jul 20, 2021·3 cites·9 claims
- 0286US9637499B2Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2015·Granted May 2, 2017·5 cites·21 claims
- 0384US9273064B2Benzodioxole or benzodioxepine heterocyclic compounds as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2014·Granted Mar 1, 2016·5 cites·19 claims
- 0482US10906915B2Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2016·Granted Feb 2, 2021·3 cites·12 claims
- 0582US10793580B2Substituted pyrazoloazepin-8-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2016·Granted Oct 6, 2020·3 cites·13 claims
- 0682US9181248B2[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2014·Granted Nov 10, 2015·5 cites·1 claims
- 0781US8362287B2Stereoselective synthesis of vitamin D analoguesLEO PHARMA AS·Filed 2005·Granted Jan 29, 2013·4 cites·17 claims
- 0880US10688108B2Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroidLEO PHARMA AS·Filed 2019·Granted Jun 23, 2020·1 cites·28 claims
- 0980US6642215B2Method of modulating NF-kB activityLEO PHARMA AS·Filed 2002·Granted Nov 4, 2003·22 cites·38 claims
- 1080US2023398131A1Pharmaceutical spray composition comprising a vitamin d analogue and corticosteroidLEO PHARMA AS·Filed 2023·Application pending·0 cites
- 1178US9908894B2Methods for the preparation of 1,3-benzodioxole heterocyclic compoundsLEO PHARMA AS·Filed 2015·Granted Mar 6, 2018·4 cites·9 claims
- 1277US8940761B2[1,2,4]triazolopyridines and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2012·Granted Jan 27, 2015·3 cites·10 claims
- 1377US8034811B2Hydroxamic acid esters and pharmaceutical use thereofLEO PHARMA AS·Filed 2004·Granted Oct 11, 2011·20 cites·24 claims
- 1476US11377425B1Small molecule modulators of IL-17LEO PHARMA AS·Filed 2019·Granted Jul 5, 2022·1 cites·73 claims
- 1575US10660908B2Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroidLEO PHARMA AS·Filed 2018·Granted May 26, 2020·0 cites·66 claims
- 1675USD709374SCartridge capLEO PHARMA AS·Filed 2012·Granted Jul 22, 2014·22 cites·1 claims
- 1774US7807682B2Pyridyl cyanoguanidine compoundsLEO PHARMA AS·Filed 2007·Granted Oct 5, 2010·2 cites·5 claims
- 1873US2024398809A1Treatment of alopecia areataLEO PHARMA AS·Filed 2024·Application pending·0 cites
- 1972US7253193B2Cyanoguanidine prodrugsLEO PHARMA AS·Filed 2003·Granted Aug 7, 2007·7 cites·18 claims
- 2071US9345774B2Topical composition comprising a film-forming polymer for delivering an active ingredient to skinLEO PHARMA AS·Filed 2013·Granted May 24, 2016·4 cites·20 claims
- 2170US10716799B2Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroidLEO PHARMA AS·Filed 2019·Granted Jul 21, 2020·0 cites·26 claims
- 2270US10682364B2Pharmaceutical spray composition comprising a vitamind D analogue and a corticosteroidLEO PHARMA AS·Filed 2019·Granted Jun 16, 2020·0 cites·27 claims
- 2370US2021128588A1Pharmaceutical spray composition comprising a vitamin d analogue and corticosteroidLEO PHARMA AS·Filed 2020·Application pending·0 cites
- 2470US2026069595A1Formulation of delgocitinib in the form of a creamLEO PHARMA AS·Filed 2025·Application pending·0 cites
- 2569US7034015B2AminobenzoephenonesLEO PHARMA AS·Filed 2002·Granted Apr 25, 2006·6 cites·22 claims
- 2668US8350026B2VEGF-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereofLEO PHARMA AS·Filed 2009·Granted Jan 8, 2013·1 cites·11 claims
- 2768US2023138114A1Treatment of hand eczemaLEO PHARMA AS·Filed 2022·Application pending·0 cites
- 2867US12043669B2IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragments thereofLEO PHARMA AS·Filed 2023·Granted Jul 23, 2024·0 cites·9 claims
- 2967US10662181B2Heteroaromatic modulators of the retinoid-related orphan receptor gammaLEO PHARMA AS·Filed 2017·Granted May 26, 2020·1 cites·23 claims
- 3066USD725470SCartridgeLEO PHARMA AS·Filed 2012·Granted Mar 31, 2015·15 cites·1 claims
- 3164US2022088020A1Treatment of alopecia areataLEO PHARMA AS·Filed 2021·Application pending·0 cites
- 3263US12065429B2Small molecule modulators of IL-17LEO PHARMA AS·Filed 2023·Granted Aug 20, 2024·0 cites·20 claims
- 3362US2022362259A1Substituted pyrazoloazepin-4-ones and their use as phosphodiesterase inhibitorsLEO PHARMA AS·Filed 2021·Application pending·0 cites
- 3462US2017065618A1Pharmaceutical spray composition comprising a vitamin d analogue and a corticosteroidLEO PHARMA AS·Filed 2016·Application pending·0 cites
- 3562US2023404909A1Microneedle patch for delivering an active ingredient to skinLEO PHARMA AS·Filed 2023·Application pending·0 cites
- 3659US10130640B2Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroidLEO PHARMA AS·Filed 2015·Granted Nov 20, 2018·0 cites·67 claims
- 3759US9855285B2Method of inhibiting the expression of IL-22 in activated T-cellsLEO PHARMA AS·Filed 2013·Granted Jan 2, 2018·1 cites·8 claims
- 3859US9566286B2Pharmaceutical spray composition comprising a vitamin D analogue and a corticosteroidLEO PHARMA AS·Filed 2015·Granted Feb 14, 2017·0 cites·19 claims
- 3959US2025197378A1Small molecule modulators of il-17LEO PHARMA AS·Filed 2023·Application pending·0 cites
- 4057USRE39706ECrystalline form of a vitamin D analogueLEO PHARMA AS·Filed 1993·Granted Jun 26, 2007·15 cites·19 claims
- 4156US2018263986A1Treatment of alopecia areataLEO PHARMA AS·Filed 2016·Application pending·0 cites
- 4255US10934282B2Heteroaromatic modulators of the retinoid-related orphan receptor gammaLEO PHARMA AS·Filed 2020·Granted Mar 2, 2021·0 cites·5 claims
- 4354US2022411517A1IL-1 Receptor Accessory Protein Inhibitors and Uses ThereofLEO PHARMA AS·Filed 2022·Application pending·0 cites
- 4452US2022241284A1Treatment of cutaneous lupus erythematosusLEO PHARMA AS·Filed 2020·Application pending·0 cites
- 4552US2023250079A1Small molecule modulators of il-17LEO PHARMA AS·Filed 2021·Application pending·0 cites
- 4651US2025275974A1Treatment of frontal fibrosing alopeciaLEO PHARMA AS·Filed 2023·Application pending·0 cites
- 4751US2023227435A1Small molecule modulators of il-17LEO PHARMA AS·Filed 2021·Application pending·0 cites
- 4850US6605742B2Cyclo azaphospha hydrocarbonsLEO PHARMA AS·Filed 2002·Granted Aug 12, 2003·1 cites·9 claims
- 4950US2014322331A1Calcipotriol monohydrate nanocrystalsLEO PHARMA AS·Filed 2014·Application pending·0 cites
- 5048US10703751B2Amino-imidazopyridine derivatives as Janus kinase inhibitors and pharmaceutical use thereofLEO PHARMA AS·Filed 2018·Granted Jul 7, 2020·0 cites·14 claims
Showing the top 50 of 80 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →